The reality of regain For patients coming off GLP-1 medications, the main expectation is straightforward: weight regain is common because obesity is a chronic condition
In contrast, the present study focuses exclusively on RCTs that directly compare at least two GLP-1 receptor agonists as monotherapies
Tirzepatide works by activating receptors for incretin hormones, which helps regulate insulin secretion and can lead to decreased appetite and caloric intake, contributing to weight loss
That aims to be the catalyst to melt away your excess pounds, rev up energy, and enhance overall health
Deficiency causes telogen effluvium and can also cause hair to become brittle and break easily
While this GLP-1 receptor agonist is celebrated for its effectiveness in managing Type 2 diabetes and promoting weight loss, its important to know that it can affect individuals differently